Jos Hoogmartens

7.7k total citations
315 papers, 6.3k citations indexed

About

Jos Hoogmartens is a scholar working on Spectroscopy, Biomedical Engineering and Pharmacology. According to data from OpenAlex, Jos Hoogmartens has authored 315 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 179 papers in Spectroscopy, 119 papers in Biomedical Engineering and 106 papers in Pharmacology. Recurrent topics in Jos Hoogmartens's work include Analytical Chemistry and Chromatography (170 papers), Microfluidic and Capillary Electrophoresis Applications (109 papers) and Antibiotics Pharmacokinetics and Efficacy (98 papers). Jos Hoogmartens is often cited by papers focused on Analytical Chemistry and Chromatography (170 papers), Microfluidic and Capillary Electrophoresis Applications (109 papers) and Antibiotics Pharmacokinetics and Efficacy (98 papers). Jos Hoogmartens collaborates with scholars based in Belgium, Hungary and Spain. Jos Hoogmartens's co-authors include Ann Van Schepdael, E. Roets, Erwin Adams, Eliangiringa Kaale, Cindy Govaerts, Yvan Vander Heyden, Gert Matthijs, G. Vantrappen, Inge Depoortere and Thierry Cachet and has published in prestigious journals such as Analytical Chemistry, Analytical Biochemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Jos Hoogmartens

312 papers receiving 6.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jos Hoogmartens Belgium 39 2.6k 2.1k 1.8k 1.5k 1.5k 315 6.3k
Ann Van Schepdael Belgium 39 1.9k 0.7× 2.4k 1.1× 1.1k 0.6× 2.0k 1.3× 842 0.6× 334 6.8k
José Barbosa Spain 45 2.8k 1.1× 1.8k 0.8× 1.6k 0.9× 1.6k 1.0× 1.8k 1.2× 218 7.3k
Erwin Adams Belgium 34 1.7k 0.6× 1.3k 0.6× 945 0.5× 1.1k 0.8× 1.0k 0.7× 275 4.3k
E. Roets Belgium 33 1.5k 0.6× 1.1k 0.5× 1.3k 0.7× 858 0.6× 877 0.6× 185 3.5k
Ulrike Holzgrabe Germany 48 2.3k 0.9× 1.5k 0.7× 1.7k 1.0× 4.3k 2.8× 1.1k 0.7× 506 10.7k
Hisao Oka Japan 36 1.1k 0.4× 463 0.2× 1.3k 0.7× 1.4k 1.0× 1.6k 1.1× 166 5.0k
Michel W. F. Nielen Netherlands 50 2.9k 1.1× 1.8k 0.9× 594 0.3× 2.0k 1.3× 1.3k 0.9× 231 8.0k
Valentino J. Stella United States 47 1.5k 0.6× 1.1k 0.5× 689 0.4× 2.7k 1.8× 755 0.5× 185 9.0k
B.K. Matuszewski United States 35 2.6k 1.0× 556 0.3× 1.8k 1.0× 2.1k 1.4× 2.0k 1.4× 122 9.2k
Fathalla Belal Egypt 38 2.2k 0.8× 779 0.4× 1.9k 1.1× 1.2k 0.8× 3.4k 2.3× 451 6.7k

Countries citing papers authored by Jos Hoogmartens

Since Specialization
Citations

This map shows the geographic impact of Jos Hoogmartens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jos Hoogmartens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jos Hoogmartens more than expected).

Fields of papers citing papers by Jos Hoogmartens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jos Hoogmartens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jos Hoogmartens. The network helps show where Jos Hoogmartens may publish in the future.

Co-authorship network of co-authors of Jos Hoogmartens

This figure shows the co-authorship network connecting the top 25 collaborators of Jos Hoogmartens. A scholar is included among the top collaborators of Jos Hoogmartens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jos Hoogmartens. Jos Hoogmartens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Farkas, Edit, et al.. (2008). Effect of long-term storage and use on the properties of reversed-phase liquid chromatographic columns. Talanta. 76(1). 172–182. 9 indexed citations
2.
Gyseghem, Elke Van, Lieven Baert, Jan Rosier, et al.. (2008). Powder for reconstitution of the anti-HIV-1 drug TMC278 – Formulation development, stability and animal studies. European Journal of Pharmaceutics and Biopharmaceutics. 70(3). 853–860. 15 indexed citations
4.
Visky, D., et al.. (2007). Facilitated column selection in reversed-phase liquid chromatography for pharmaceutical separations. 20. 82–96. 15 indexed citations
5.
Noszál, Béla, et al.. (2006). Application of an improved column characterisation system to evaluate the within and between batch variability. Journal of Pharmaceutical and Biomedical Analysis. 44(3). 634–639. 19 indexed citations
6.
Adams, Erwin, et al.. (2006). Application of liquid chromatography/ion trap mass spectrometry to the characterization of the related substances of clarithromycin. Rapid Communications in Mass Spectrometry. 20(20). 3101–3110. 12 indexed citations
7.
Zhang, Jie, Yijia Lou, Jos Hoogmartens, & Ann Van Schepdael. (2006). Screening of drug metabolism by CE. Electrophoresis. 27(23). 4827–4835. 5 indexed citations
8.
Hoogmartens, Jos, et al.. (2005). Method development and validation for the analysis of didanosine using micellar electrokinetic capillary chromatography. Electrophoresis. 26(21). 4079–4088. 9 indexed citations
9.
Dehouck, Pieter, D. Visky, Erwin Adams, et al.. (2004). Facilitated Column Ranking and Selection in Reversed-Phase Liquid Chromatographic Analysis. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 17(11). 592–601. 33 indexed citations
10.
Dehouck, Pieter, et al.. (2003). Analysis of erythromycin and benzoylperoxide in topical gels by liquid chromatography. Journal of Chromatography B. 794(2). 293–302. 18 indexed citations
11.
Kaale, Eliangiringa, Ann Van Schepdael, E. Roets, & Jos Hoogmartens. (2002). Aminoglycoside antibiotics: A decade's overview of capillary electrophoresis analysis. 34(21). 22–26. 2 indexed citations
12.
Roets, E., et al.. (2001). Quantitative determination of olaquindox in animal feed. 14(5). 347–349. 1 indexed citations
13.
Dehouck, Pieter, Ann Van Schepdael, E. Roets, & Jos Hoogmartens. (2001). Analysis of clindamycin by micellar electrokinetic chromatography with a mixed micellar system. Journal of Chromatography A. 932(1-2). 145–152. 10 indexed citations
14.
Adams, Erwin, et al.. (1997). Analysis of kanamycin sulfate by liquid chromatography with pulsed electrochemical detection. Journal of Chromatography A. 766(1-2). 133–139. 50 indexed citations
15.
Weng, Naidong, et al.. (1994). Purity control of six tetracyclines by semi-quantitative TLC with fluorescence detection. 7(4). 297–300. 1 indexed citations
16.
Khan, Kashif Maqbool, et al.. (1994). Quantitative TLC of erythromycin: application to commercial bulk samples and biological samples. 7(5). 349–353. 1 indexed citations
17.
Beer, Jacques O. De & Jos Hoogmartens. (1993). Experimental design on liquid chromatographic parameters in the analysis of tetracycline on poly(styrene—divinylbenzene). Journal of Pharmaceutical and Biomedical Analysis. 11(11-12). 1239–1250. 15 indexed citations
18.
Weng, Naidong, et al.. (1991). Determination of metacycline and related substances by column liquid chromatography on poly(styrene-divinylbenzene). Journal of Chromatography A. 586(1). 61–66. 19 indexed citations
19.
Hoogmartens, Jos, et al.. (1988). The determination of water in erythromycin by Karl Fischer titration. Journal of Pharmaceutical and Biomedical Analysis. 6(5). 461–472. 13 indexed citations
20.
Hoogmartens, Jos, et al.. (1988). High-performance liquid-chromatography of chlortetracycline. Pharmacy World & Science. 10(1). 64–64.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026